Epigallocatechin-3-Gallate (EGCG) Ameliorates Ineffective Hematopoiesis of Myelodysplasia Syndrome (MDS)

被引：0
|
作者：
Della Via, Fernanda Isabel [1 ]
Ferro, Karla Priscila [2 ]
Assis-Mendonca, Guilherme Rossi [3 ]
Santos, Irene [1 ]
Amor, Nadia Ghinelli [1 ]
Pericole, Fernando Vieira [4 ]
De Prax, Marisa Claudia [4 ]
Olalla Saad, Sara Teresinha [1 ]
机构：
[1] Univ Estadual Campinas, Hematol & Transfus Med Ctr Hemoctr, Campinas, Brazil
[2] Univ Estadual Campinas, Hematol & Transfus Med Ctr, Hemoctr, Hemoctr,UNICAMP, Campinas, Brazil
[3] Univ Estadual Campinas, Sch Med Sci, Dept Pathol, UNICAMP, Campinas, Brazil
[4] Hemoctr Unicamp, Campinas, Brazil
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186607
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
    Marin, Victor
    Burgos, Viviana
    Perez, Rebeca
    Maria, Durvanei Augusto
    Pardi, Paulo
    Paz, Cristian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [22] Epigallocatechin-3-gallate (EGCG) binds to TTR and modulates its amyloidogenicity
    Ferreira, N.
    Cardoso, I.
    Domingues, M. R.
    Vitorino, R.
    Bastos, M.
    Bai, G.
    Saraiva, M. J.
    Almeida, M. R.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 103 - 103
  • [23] Epigallocatechin-3-gallate (EGCG) enhances the therapeutic activity of a dental adhesive
    Du, Xijin
    Huang, Xueqing
    Huang, Cui
    Wang, Yake
    Zhang, Yufeng
    JOURNAL OF DENTISTRY, 2012, 40 (06) : 485 - 492
  • [24] Epigallocatechin-3-gallate ameliorates alcoholinduced liver injury in rats
    Yuan, Gungjin
    Gong, Zuo-Jiong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A107 - A107
  • [25] Effect of dietary (-)-epigallocatechin-3-gallate (EGCG) pretreatment on the hepatotoxicity of acute high dose EGCG
    James, Karma
    Forester, Sarah
    Lambert, Joshua
    FASEB JOURNAL, 2014, 28 (01):
  • [26] Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy
    Lecumberri, Elena
    Dupertuis, Yves Marc
    Miralbell, Raymond
    Pichard, Claude
    CLINICAL NUTRITION, 2013, 32 (06) : 894 - 903
  • [27] The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor
    Cheng, Xiao-Rui
    Zhou, Jin-Wu
    Zhou, Yu
    Cheng, Jun-Ping
    Yang, Ri-Fang
    Zhou, Wen-Xia
    Zhang, Yong-xiang
    Yun, Liu-Hong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (03) : 1408 - 1414
  • [28] Evaluation of epigallocatechin-3-gallate (EGCG)-modified scaffold determines macrophage recruitment
    Chu, Chenyu
    Liu, Li
    Wang, Yuanjing
    Yang, Renli
    Hu, Chen
    Rung, Shengan
    Man, Yi
    Qu, Yili
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2019, 100 : 505 - 513
  • [29] The anti-hyperuricemic effect of epigallocatechin-3-gallate (EGCG) on hyperuricemic mice
    Zhu, Chuang
    Xu, Yan
    Liu, Zeng-Hui
    Wan, Xiao-Chun
    Li, Da-Xiang
    Tai, Ling-Ling
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 168 - 173
  • [30] Epigallocatechin-3-gallate (EGCG) inhibits IL-1β signal transduction
    Wheeler, DS
    Odoms, K
    Denenberg, AE
    Wong, HR
    CRITICAL CARE MEDICINE, 2002, 30 (12) : A11 - A11
12345